Stocks · Healthcare · Medical - Instruments & Supplies
Intuitive Surgical, Inc. ISRG
$391.95 -2.32% Close, Oct 2, 2026 · NASDAQ · Market cap $138.47B
High quality
Next earnings report: Oct 20, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +14.1%).
- The shares trade at 44.6× trailing earnings, lower than 95% of the company's own readings over the past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 32%
- EPS growth (TTM, YoY)Top 39%
- FCF growth (TTM, YoY)Top 25%
- Revenue growth, 3-year CAGRTop 35%
- Revenue growth accelerationBottom 44%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 8%
- Gross marginTop 47%
- Operating marginTop 6%
- Cash conversion (OCF / net income)Bottom 30%
- Accruals (lower is better)Bottom 28%
- Net debt / EBITDA (lower is better)Top 24%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 23%
- Free-cash-flow yieldTop 28%
- EBITDA / enterprise valueTop 29%
- Sales / enterprise valueBottom 27%
- P/E vs own 5-year history (lower is better)Top 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 26%
- 6-month returnBottom 29%
- 1-year return vs S&P 500Bottom 35%
- Distance from 52-week highBottom 46%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 31%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyBottom 39%
- Upside to consensus price targetBottom 30%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 37%
- Maximum drawdown, 3 yearsTop 18%
- Beta vs S&P 500 (lower is better)Bottom 45%
- Net debt / EBITDA (lower is better)Top 24%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 21.4% | 20.7% | ↓ |
| EPS growth (YoY) | 21.0% | 22.6% | ↑ |
| Gross margin | 66.6% | 66.7% | ↑ |
| Operating margin | 28.8% | 31.3% | ↑ |
| FCF margin | 21.8% | 29.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 20.7% | 21.4% | ↓ | Top 32% |
| EPS growth (TTM, YoY) | 22.6% | 21.0% | ↑ | Top 39% |
| Gross margin | 66.7% | 66.6% | ↑ | Top 47% |
| Operating margin | 31.3% | 28.8% | ↑ | Top 6% |
| Net margin | 28.4% | 28.5% | ↓ | — |
| Free-cash-flow margin | 29.2% | 21.8% | ↑ | — |
| Return on invested capital | 15.1% | — | Top 8% | |
| Revenue growth, 3-year CAGR | 17.4% | — | Top 35% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.18×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 7.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +6.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.61×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.31%
- Shareholder yield
- 2.31%
- Share count change, 1 year
- -1.5%
- Share count change, 3-year CAGR
- +0.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 21, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +14.1%
- Average 2-day reaction, last 8
- +0.3%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $491.15
- Target vs current price
- +25.3%
- Analysts with a rating
- 57
- Share rating Buy or Strong Buy
- 70%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 16, 2026 | +12.9% | +3.4% | -12.4% | +3.2% | — |
| Apr 21, 2026 | +11.6% | -3.1% | +1.2% | -5.5% | -13.6% |
| Jan 22, 2026 | +11.5% | +0.4% | -0.3% | -4.6% | -10.4% |
| Oct 21, 2025 | +20.6% | +0.9% | +20.2% | +19.2% | +18.1% |
| Jul 22, 2025 | +13.5% | -1.0% | -4.3% | -6.8% | -15.4% |
| Apr 22, 2025 | +4.0% | +2.2% | +9.8% | +19.9% | +10.2% |
| Jan 23, 2025 | +25.6% | -0.3% | -6.2% | -0.6% | -20.9% |
| Oct 17, 2024 | +12.9% | -0.6% | +7.6% | +12.6% | +13.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 16, 2026 | $2.80 | $2.48 | +12.9% | $2.89B |
| Apr 21, 2026 | $2.80 | $2.51 | +11.6% | $2.77B |
| Jan 22, 2026 | $2.53 | $2.27 | +11.5% | $2.87B |
| Oct 21, 2025 | $2.40 | $1.99 | +20.6% | $2.51B |
| Jul 22, 2025 | $2.19 | $1.93 | +13.5% | $2.44B |
| Apr 22, 2025 | $1.81 | $1.74 | +4.0% | $2.25B |
| Jan 23, 2025 | $2.21 | $1.76 | +25.6% | $2.41B |
| Oct 17, 2024 | $1.84 | $1.63 | +12.9% | $2.04B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 44.6× | 69.7× | 5th | Top 23% |
| P/E (forward) | 36.3× | — | — | — |
| EV / EBITDA | 30.1× | — | — | Top 29% |
| EV / Sales | 12.30× | — | — | Bottom 27% |
| Free-cash-flow yield | 2.33% | — | — | Top 28% |
| Earnings yield | 2.24% | — | — | Top 23% |
P/E over the past five years
Range 39.8× – 89.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -10.5%
- Earnings per share growth (TTM)
- +22.6%
- Change in P/E multiple
- -43.1%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 15
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -0.4%
- 200-day average slope (20 days)
- -3.8%
- Distance from 50-day average
- +3.1%
- Distance from 200-day average
- -12.4%
- RSI (14)
- 51.2
- Relative volume
- 0.76×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 48.5%
- Volatility vs own 5-year history
- 89th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.20
- Correlation with S&P 500
- 0.53
- Current drawdown from 1-year high
- -33.9%
- Maximum drawdown, 3 years
- -45.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 8, 2021 | Oct 14, 2022 | -49.9% | 235 days | 315 days (Jan 18, 2024) |
| Jan 22, 2025 | Jul 23, 2026 | -45.6% | 376 days | Not yet recovered |
| Jan 8, 2021 | Mar 8, 2021 | -16.4% | 39 days | 31 days (Apr 21, 2021) |
| Oct 12, 2020 | Oct 30, 2020 | -11.7% | 14 days | 6 days (Nov 9, 2020) |
| Sep 8, 2021 | Oct 4, 2021 | -10.3% | 18 days | 19 days (Oct 29, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $138.47B
- P/E (TTM)
- 44.6
- EPS, diluted (TTM)
- $8.79
- Revenue (TTM)
- $11.03B
- 52-week range
- $328.57 – $603.88
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $5.71B | $6.22B | $7.12B | $8.35B | $10.06B |
| Gross profit | $3.96B | $4.20B | $4.73B | $5.63B | $6.64B |
| Operating income | $1.82B | $1.58B | $1.77B | $2.35B | $2.95B |
| Net income | $1.70B | $1.32B | $1.80B | $2.32B | $2.86B |
| EPS (diluted) | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.04B | $2.41B | $2.25B | $2.44B | $2.51B | $2.87B | $2.77B | $2.89B |
| Net income | $565.1M | $685.7M | $698.4M | $658.4M | $704.4M | $794.8M | $821.5M | $818.1M |
| EPS (diluted) | $1.56 | $1.88 | $1.92 | $1.81 | $1.95 | $2.21 | $2.28 | $2.35 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $2.09B | $1.49B | $1.81B | $2.42B | $3.03B |
| Capital expenditure | -$353.5M | -$532.4M | -$1.06B | -$1.11B | -$539.8M |
| Free cash flow | $1.74B | $958.4M | $749.6M | $1.30B | $2.49B |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $276.5M | -$2.61B | -$120.0M | $429.4M | -$1.95B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $5.22B
- Total assets
- $20.88B
- Total liabilities
- $2.58B
- Total debt
- $0
- Net debt
- -$2.76B
- Shareholders’ equity
- $18.17B
As of Jun 30, 2026 (filed Jul 21, 2026).
Short interest
- Shares sold short
- 8,117,017
- Days to cover
- 3.35
- Change vs previous report
- +5.0%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 5, 2021
- 3-for-1
- Oct 6, 2017
- 3-for-1
- Jul 1, 2003
- 1-for-2